共 70 条
[11]
Clark DE(1997)Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 23 3-25
[12]
Pickett SD(1979)The functional importance of structural features of ergosterol in yeast J Biol Chem 253 6218-6225
[13]
Clark M(1991)Synthesis and structure-activity relationships of benzo[b]thienylallylamine antimycotics J Med Chem 34 65-73
[14]
Cramer RD(1993)Synthesis and structure-activity relationships of phenyl substituted benzylamine antimycotics: a novel benzylbenzylamine antifungal agent for systemic treatment J Med Chem 36 2115-2120
[15]
Van Opdenbosch N(1993)Synthesis and structure-activity relationships of naphthalene substituted derivatives of the allylamine antimycotic terbinafine J Med Chem 36 2810-2816
[16]
Denning DW(1994)Synthesis and structure-activity relationships of the novel homopargylamine antimycotics J Med Chem 37 610-615
[17]
Diamond RD(1995)Synthesis and structure-activity relationships of the allylamine antimycotic terbinafine lacking the central amino function J Med Chem 38 1831-1836
[18]
Gokhale VM(1993)Resistance of yeasts to azole derivative antifungals J Antimicrob Chemother 31 463-471
[19]
Kulkarni VM(1982)Squalene and ergosterol biosynthesis in fungi treated with naftifine, a new antimycotic agent Biochimica et Biophysica Acta (BBA) – Lipids and Lipid Metabolism 712 268-273
[20]
Hitchcock CA(1984)Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase Science 224 1239-1241